The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study

SIMPLE SUMMARY: The first-line systemic therapy for advanced hepatocellular carcinoma (HCC) is atezolizumab plus bevacizumab therapy in many guidelines for HCC, however, there are no established therapeutic strategies in patients with intermediate stage and beyond the combination therapy. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuchiya, Kaoru, Kurosaki, Masayuki, Sakamoto, Azusa, Marusawa, Hiroyuki, Kojima, Yuji, Hasebe, Chitomi, Arai, Hirotaka, Joko, Kouji, Kondo, Masahiko, Tsuji, Keiji, Sohda, Tetsuro, Kimura, Hiroyuki, Ogawa, Chikara, Uchida, Yasushi, Wada, Shuichi, Kobashi, Haruhiko, Furuta, Koichiro, Shigeno, Masaya, Kusakabe, Atsunori, Akahane, Takehiro, Narita, Ryoichi, Yoshida, Hideo, Mitsuda, Akeri, Ide, Yasushi, Matsushita, Tomomichi, Izumi, Namiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198233/
https://www.ncbi.nlm.nih.gov/pubmed/34073396
http://dx.doi.org/10.3390/cancers13112608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198233/
https://www.ncbi.nlm.nih.gov/pubmed/34073396
http://dx.doi.org/10.3390/cancers13112608

Ejemplares similares